DrugPatentWatch Database Preview
Drugs in Development Information for ISV-305
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug ISV-305?
ISV-305 is an investigational drug.
There have been 14 clinical trials for ISV-305.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2012.
The most common disease conditions in clinical trials are Cataract, Inflammation, and Conjunctivitis, Bacterial. The leading clinical trial sponsors are InSite Vision, Bausch & Lomb Incorporated, and Dartmouth-Hitchcock Medical Center.
Summary for ISV-305
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,507 |
| WIPO Patent Applications | 2,810 |
| Japanese Patent Applications | 19 |
| Clinical Trial Progress | Phase 3 (2012-07-01) |
| Vendors | 68 |
Recent Clinical Trials for ISV-305
| Title | Sponsor | Phase |
|---|---|---|
| A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease | InSite Vision | Phase 2 |
| Comparative Study to Evaluate ISV-305 Compared to Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery | InSite Vision | Phase 3 |
| Independent Comparative Study to Evaluate ISV-305 Compared to Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery | InSite Vision | Phase 3 |
Clinical Trial Summary for ISV-305
Top disease conditions for ISV-305
Top clinical trial sponsors for ISV-305
US Patents for ISV-305
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
